Lipid lowering goals: back to nature?
نویسندگان
چکیده
منابع مشابه
Getting Back to Nature
EVALUATIVE PROPERTIES ARE often thought to be problematic. E.g., they are said to be “unverifiable,” to “play no role in observation,” to be “queer,” to suffer from a “location problem,” and indeed “not [to be] in this world at all.”1 These charges differ in detail, and there are a variety of ways of responding to them.2 However, one general way of vindicating evaluative properties is to show t...
متن کاملStatins: Newer Roles Including Lipid Lowering Therapy
Statins are most effective pharmacologically agents to decrease total plasma cholesterol level by competitive inhibition of HMG-Co A reductase. Apart from the well-known LDL and cholesterol lowering effect, statins have been postulated to exert other beneficial effects also called pleotropic or non-lipid effects. Better understanding of various pleotropic effects of statins has prompted a new s...
متن کامل[Up to date lipid lowering treatment].
Considerable evidence suggests that "the lower the better" is a reasonable approach for reducing cardiovascular risk by lowering LDL cholesterol levels. Despite the reduction in cardiovascular events and mortality achieved by statin therapy, significant residual risk remains, especially in severe hereditary hypercholesterolemia, such as familial hypercholesterolemia. Some new strategies to achi...
متن کاملCost-effectiveness of lipid-lowering treatment according to lipid level.
BACKGROUND Recent studies suggest that the benefit of lipid-lowering treatment for the primary and secondary prevention of cardiovascular disease (CVD) extends to individuals with average cholesterol levels, to women and to the elderly. However, the proportion of the general population for which treatment is cost-effective has not been evaluated. OBJECTIVES AND METHODS Using data provided by ...
متن کاملHeterogeneity of response to lipid-lowering therapy.
the follow-up (from 3 to 2 and 0), simply after evaluating them, performing the tilt table test and explaining the pathogenesis of the disease. This fact may explain Dr. Sra’s (2) skepticism on the medical capacity to prove the benefit of any treatment for vasovagal syncope. This could also be the reason why almost any treatment that has been tested for the therapy of vasovagal syncope has been...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Cardiovascular Disease
سال: 2010
ISSN: 1753-9447,1753-9455
DOI: 10.1177/1753944710368206